Disclaimer

The trademark information displayed on this page is public information and is provided for informational purposes only. This information may be incomplete, inaccurate, or outdated, and IndiaFilings does not guarantee its accuracy. IndiaFilings is an independent platform and is not associated, affiliated, or connected with any trademark listed in this database. We do not represent or speak on behalf of any such trademark. If you are trying to contact a specific trademark, please use their official channels. IndiaFilings cannot assist with queries directed at other companies.

CEFDOX

Class 5Status: Objected
Application Number5640488
Trademark Status
Objected
Trademark Class5
Application Date2022-10-08
Proprietor NameJAMUNA DAS KESHARI TRADING AS CARRON PHARMACEUTICALS
Appropriate OfficeMUMBAI
StateMAHARASHTRA
Trademark TypeWORD
User Details10/06/2020
Agent NameADITYA & CO.[914]
Agent Address33-HABIB BUILDING, G.K. MARG LOWER PAREL, MUMBAI-400013
Goods And Services Details[CLASS : 5] MEDICINAL, PHARMACEUTICAL AND VETERINARY PREPARATIONS

Identical Trademarks

Similar trademarks found for this brand

3 found
BrandClassStatus
CEFDOX5Objected
CEFDOX5Objected
CEFDOX5Objected
Showing up to 6 identical trademarksView more on LEDGERS→

Trademark Protection

Automate the monitoring of your trademark application and filing of response to Government Objection or Hearing.

₹9,899+ GST

What's included:

✓
Brand Guard ( 1 application 1 class)
✓
Appointment of Lawyer
✓
Objection
✓
Hearing
✓
Infringement support (1)
✓
Power of Attorney (POA)

Frequently asked questions

Common questions about CEFDOX.

What is the status of trademark application 5640488?
The current status of trademark application 5640488 for CEFDOX is Objected.
What is the trademark class of CEFDOX?
CEFDOX is registered under trademark class 5.
Who is the proprietor of CEFDOX?
The proprietor of CEFDOX is JAMUNA DAS KESHARI TRADING AS CARRON PHARMACEUTICALS.
When was trademark application 5640488 filed?
Trademark application 5640488 for CEFDOX was filed on 2022-10-08.